Maharashtra FDA chief Tukaram Mundhe steps up statewide food and drug safety enforcement

Commissioner Tukaram Mundhe is leading Maharashtra FDA action against food adulteration, unsafe products, counterfeit medicines and banned goods, with inspections and raids spanning manufacturers, wholesalers, restaurants, dairies and retailers.

— Source publishedThu, 6 Aug, 2026, 12:44 IST·First seen Thu, 6 Aug, 2026, 13:11 IST·Source Business Today · Latest

What happened

Maharashtra Food and Drug Administration · Maharashtra FDA Commissioner Tukaram Mundhe is leading statewide enforcement against food adulteration, unsafe

Key facts

  • 25 transfers
  • 21-year IAS career
  • 2005 batch
  • May 2026

Why this matters

Acquirers and partners should elevate food-safety, counterfeit-control and regulatory diligence for Maharashtra targets, as compliance gaps could create material liabilities or valuation pressure.

What to watch

  • Volume and geographic spread of FDA raids, samples collected, stop-sale orders, license suspensions and prosecutions.
  • Named actions involving large manufacturers, dairy cooperatives, pharmacy distributors, restaurant chains or e-commerce sellers.
  • New Maharashtra directives on labelling, food testing, cold-chain compliance, drug traceability or retailer recordkeeping.
  • Reported failures in dairy, edible oils, spices, sweets, supplements, cosmetics and counterfeit-drug supply chains.
  • Increased supplier lead times, price revisions, requests for advance payments or inability to provide documentation.
  • Whether enforcement expands beyond Mumbai and major cities into wholesale markets and district-level retail networks.
  • Audit Maharashtra suppliers for FDA licenses, manufacturing registrations, batch traceability, test certificates and recall-response obligations.
  • Prioritize enhanced incoming-quality checks for dairy, oils, spices, packaged sweets, nutraceuticals, cosmetics, OTC medicines and cold-chain products.
  • Create contingency sourcing for top-selling SKUs where supply depends on small manufacturers, distributors or local wholesalers.
  • Require pharmacies and marketplace sellers to document authorized distribution channels, invoices and batch-level provenance for medicines and health products.
  • Review private-label contracts to shift recall, testing, indemnity and regulatory-notice costs to qualified manufacturers.
  • Prepare store-level protocols for seizure notices, product holds, regulator inspections and customer communications.